Evaluation of clinical efficiency of Decap replacement therapy in patients with type 2 diabetes mellitus and concomitant nonalcoholic fatty liver disease in vitamin D deficiency
Background. Recently, vitamin D deficiency has been considered one of the factors in the development of type 2 diabetes mellitus (DM) and nonalcoholic fatty liver disease (NAFLD). The purpose was to establish the effectiveness of Decap (cholecalciferol) in patients with its deficiency who suffered...
Main Authors: | М.B. Аludwan, N.M. Kobyliak, G.P. Pavlenko, Yu.I. Komisarenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaslavsky O.Yu.
2020-11-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Subjects: | |
Online Access: | http://iej.zaslavsky.com.ua/article/view/222881 |
Similar Items
-
General decapping activators target different subsets of inefficiently translated mRNAs
by: Feng He, et al.
Published: (2018-12-01) -
Decapping factor Dcp2 controls mRNA abundance and translation to adjust metabolism and filamentation to nutrient availability
by: Anil Kumar Vijjamarri, et al.
Published: (2023-06-01) -
A Poxvirus Decapping Enzyme Colocalizes with Mitochondria To Regulate RNA Metabolism and Translation and Promote Viral Replication
by: Shuai Cao, et al.
Published: (2022-06-01) -
Global Analysis of the Human RNA Degradome Reveals Widespread Decapped and Endonucleolytic Cleaved Transcripts
by: Jung-Im Won, et al.
Published: (2020-09-01) -
mRNA Decapping Factors LSM1 and PAT Paralogs Are Involved in Turnip Mosaic Virus Viral Infection
by: Zhangli Zuo, et al.
Published: (2022-02-01)